Skip to content

To study the effectiveness of sitcom tablet and sitcom cream in haemorrhoids during pregnancy

Study to evaluate the efficacy and safety of sitcom tablet (euphorbia prostrata dry Extract 100 mg) and sitcom cream (euphorbia prostrata dry Extract cream) in treatment of haemorrhoids during pregnancy.

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/039010
Enrollment
100
Registered
2021-12-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O224- Hemorrhoids in pregnancy

Interventions

Intervention1: Sitcom tablet: 100mg tablet Once Daily for 14 days. Intervention2: Sitcom cream: To be applied locally at least twice daily and after each act of defecation for 14 days. Control Interve

Sponsors

Healing Hands Clinic
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pregnant Female patient, at least 18 years of age with a complaint of hemorrhoids during pregnancy. 2.Patient is willing to participate in the current study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Lactating women. Women in post –partum period of up to 6 weeks. 2.Patient having hypersensitive predisposition or hypersensitive to any of components of the study drug 3.Clinically significant co-morbid condition that in the opinion of the investigator could affect patient.

Design outcomes

Primary

MeasureTime frame
1.Cessation of per rectal bleeding 2.Relief from pain at defecation 3.Relief from Itching, exudation and swelling 4.Re-treatment initiation required during study duration 5.Overall improvement in disease condition (assessed by Patients and Physicians) V3 End of 2 week 6.For Hemorrhoids Overall improvement in disease condition assessed by Patients 7.Overall improvement in disease condition assessed by Physician Timepoint: 4 week

Secondary

MeasureTime frame
1.Number of Adverse Events during the study duration.Timepoint: 2 months

Countries

India

Contacts

Public ContactDr Ashwin Porwal

Healing Hands Clinic

drashwinporwal@gmail.com9822347770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026